High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma

Abstract

Excellent vaginal/pelvic control rates were observed. Further study of HDR brachytherapy dose and fractionation in combination with chemotherapy is worthwhile.